Ovarian cancer cells are "addicted" to a family of proteins produced by the notorious oncogene, MYC, and blocking these Myc proteins halts cell proliferation in the deadliest cancer of the female ...
... with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive ...
... with chronic myeloid leukaemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive ...
... "TG2 appears to fuel different types of cancer through multiple molecular pathways, making it ... death, or apoptosis. "When exposed to this potent targeted therapy, ovarian cancer cells greatly reduced ...
... from diagnosis.
This approach was originally developed in ovarian cancer cells by study co-author Janet Sawicki ... allows the toxin to then do its work on the cancer cells, Brody says. Within 24 hours ...
... phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less ... carboplatin because they don't penetrate the cell nucleus and attach to DNA, said lead author ...
... understanding, and perhaps killing, dormant ovarian cancer cells that persist after initial treatment only to reawaken ... grew rapidly.
"Cancer cells had remained viable during ARHI-induced growth arrest ...
... called ARHI acts as a switch for autophagy, or self-cannibalization, in ovarian cancer cells. Often a mechanism for cancer cell death, in this case "self-eating" acts as a survival mechanism for ...
... apply targeted therapies to individual patients and their cancers in order to augment response to treatment while ... study, researchers examined four ovarian cancer cell lines, known as IGROV1, SKOV3, ...
... a promising approach to orchestrate an attack against a cancer whose survival rates have barely budged over ... take them up.
Samples of human ovarian cancer cells show similar responses to nanoparticle ...
... Francisco.
In 30-60 percent of human ovarian tumors, MYC is overly active, or amplified, usually ... experimentally amplified did not affect ovarian cancer cell growth.
The scientists suspect that even ...
... 140,000 women worldwide die from ovarian cancer each year. The vast majority ... carry information for the production of specific proteins) in ovarian cancer cells, searching for evidence of proteins ...
... cancer mouse models prolonged lifespan by nearly four weeks and suppressed tumor growth ... research is the multiple ways it can target ovarian cancer cells, as scientists were able to deliver diphtheria ...
... and colon cancer cells.
The compounds were also effective against ovarian cancer cells which are resistant to the drug Cisplatin, the most successful transition metal drug, which contains the metal ...
... ferry a potent medication inside a resistant cell is a bit like recruiting your grandmother ... tried it out against Taxol-resistant ovarian cancer cells implanted in mice. It worked.
"It's an exciting ...
